VANECK ETF TRUST - PHARMACEUTCL ETF (PPH)

Historical Portfolio Holders from Q1 2016 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / PHARMACEUTCL ETF
Shares, excl. options Q3 2024
5.66M
Holdings value Q3 2024
$538M
Value change Q3 2024
+$85.8M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
135
Number of buys Q3 2024
68
Number of sells Q3 2024
-57
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 5.66M $538M +$85.8M $95.03 135
2024 Q2 4.79M $438M +$21M $91.48 140
2024 Q1 4.48M $407M -$6.24M $90.70 132
2023 Q4 4.69M $382M -$16M $81.37 106
2023 Q3 5.01M $400M +$20.9M $79.86 99
2023 Q2 4.92M $388M +$6.16M $78.77 98
2023 Q1 4.55M $353M -$178M $77.63 101
2022 Q4 6.55M $509M +$29.6M $77.74 109
2022 Q3 6.32M $427M +$119M $67.24 84
2022 Q2 4.5M $346M +$274M $76.84 89
2022 Q1 877K $70M +$7.48M $79.76 72
2021 Q4 764K $58.8M -$6.58M $76.95 60
2021 Q3 775K $56.4M +$3.05M $72.81 49
2021 Q2 861K $62.9M -$122M $73.07 51
2021 Q1 2.72M $188M +$79.8M $69.02 52
2020 Q4 1.39M $92.7M -$36.8M $66.48 52
2020 Q3 1.95M $121M +$27M $62.16 48
2020 Q2 1.52M $94.4M +$34.8M $62.25 46
2020 Q1 1.06M $57.7M -$79.3M $54.39 44
2019 Q4 3.21M $206M +$11M $64.18 48
2019 Q3 2.27M $129M +$52M $56.95 42
2019 Q2 952K $55.8M -$3.05M $58.67 40
2019 Q1 1M $60.8M -$33.9M $60.70 43
2018 Q4 1.56M $85.5M -$19.8M $54.79 44
2018 Q3 1.9M $122M -$19.1M $64.34 41
2018 Q2 2.21M $130M +$13.8M $59.00 47
2018 Q1 1.98M $113M +$23.5M $56.82 50
2017 Q4 1.57M $92.9M -$67.1M $59.31 48
2017 Q3 2.35M $136M +$67.6M $57.76 46
2017 Q2 1.2M $70.8M -$41.2M $59.06 48
2017 Q1 1.9M $105M +$2.25M $55.14 48
2016 Q4 1.86M $97.8M -$64.4M $52.51 48
2016 Q3 3.07M $176M +$40.1M $57.46 54
2016 Q2 2.37M $140M +$139M $58.62 51
2016 Q1 10.8K $623K +$623K $57.52 2